These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14985333)

  • 1. Modulation of beta-catenin phosphorylation/degradation by cyclin-dependent kinase 2.
    Park CS; Kim SI; Lee MS; Youn CY; Kim DJ; Jho EH; Song WK
    J Biol Chem; 2004 May; 279(19):19592-9. PubMed ID: 14985333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 2 regulates the interaction of Axin with beta-catenin.
    Kim SI; Park CS; Lee MS; Kwon MS; Jho EH; Song WK
    Biochem Biophys Res Commun; 2004 Apr; 317(2):478-83. PubMed ID: 15063782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-catenin is a target for the ubiquitin-proteasome pathway.
    Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
    EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif.
    Zhu H; Nie L; Maki CG
    J Biol Chem; 2005 Aug; 280(32):29282-8. PubMed ID: 15964852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway.
    Yun J; Chae HD; Choi TS; Kim EH; Bang YJ; Chung J; Choi KS; Mantovani R; Shin DY
    J Biol Chem; 2003 Sep; 278(38):36966-72. PubMed ID: 12857729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
    Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
    Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG
    Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
    Christian SL; Sims PV; Gold MR
    J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of a glycogen synthase kinase-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling.
    Kirschenbaum F; Hsu SC; Cordell B; McCarthy JV
    J Biol Chem; 2001 Mar; 276(10):7366-75. PubMed ID: 11104755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
    Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
    Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation.
    Li H; Liu L; David ML; Whitehead CM; Chen M; Fetter JR; Sperl GJ; Pamukcu R; Thompson WJ
    Biochem Pharmacol; 2002 Nov; 64(9):1325-36. PubMed ID: 12392815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells.
    Tintignac LA; Leibovitch MP; Kitzmann M; Fernandez A; Ducommun B; Meijer L; Leibovitch SA
    Exp Cell Res; 2000 Aug; 259(1):300-7. PubMed ID: 10942602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta induced G(1) cell cycle arrest requires the activity of the proteasome pathway. Transforming growth factor.
    Zhang F; Mönkkönen M; Roth S; Laiho M
    Exp Cell Res; 2002 Dec; 281(2):190-6. PubMed ID: 12460649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
    Easwaran V; Song V; Polakis P; Byers S
    J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
    Clurman BE; Sheaff RJ; Thress K; Groudine M; Roberts JM
    Genes Dev; 1996 Aug; 10(16):1979-90. PubMed ID: 8769642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2.
    Lents NH; Keenan SM; Bellone C; Baldassare JJ
    J Biol Chem; 2002 Dec; 277(49):47469-75. PubMed ID: 12359725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome-mediated destruction of the cyclin a/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivo.
    Chen W; Lee J; Cho SY; Fine HA
    Cancer Res; 2004 Jun; 64(11):3949-57. PubMed ID: 15173007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.